[1] The company is now one of the largest manufacturer and supplier of high-precision injection mould and plastic parts in Asia. With plants in China, Malaysia, SG, it's serving wide range of sectors such as telecommunication, automotive, medical, etc.
[2] It's net income is on track to beat 14mil which was the peak of past 5 years. The earning growth mainly due to expansion in automotive, medical and consumer segments.
[3] Benefited from rising USD, due to majority of topline is in US currency.
HIGHLIGHTS:
[1] It has net cash 77mil, which translates to 0.1026 per share. Consistent dividend paid 0.016, ~ 8.8% yield.
[2] Last trading price 0.18 translates P/B ~ 0.8. Considering current attractive valuation, it could be potential privatization target.
[3] Downside risk could be worsening trade war between US-China.
CHART:
The counter has been trading below it's book value 0.216 for year to date. ~ 30% lower than it's peak ~ 0.26 on FY2017. Last 5 months saw the price moving in narrow range. Accumulation on weakness~
No comments:
Post a Comment